Delivery Order SPE2DB22D3016-SPE2DB24FASA9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.65 firm-fixed-price delivery order is for the supply of Focalin XR 5 mg capsules. The contract has an ultimate completion date of February 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,797.26 to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,564,359,688 units of Focalin XR 5 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,023.02 firm fixed-price delivery order is for the supply of Focalin XR 5 mg capsules. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,063.62 firm fixed-price delivery order is for the supply of Focalin XR 10 mg capsules, with a period of performance through March 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,679.20 firm fixed-price delivery order is for the supply of 4,566,528,871 units of the prescription medication Focalin XR 20 mg capsules. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,104.75, is for the supply of FOCALIN XR CAPS 10MG, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $4,535.48 firm-fixed-price contract is for the supply of 4,566,280,805 units of Focalin XR 10 mg capsules. The contract has an ultimate completion date of October 31, 2024. There was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,017.11 firm fixed-price delivery order is for the supply of 4,566,277,104 units of the prescription medication FOCALIN XR 10 MG CAPSULE 100S. The contract has an ultimate completion date of October 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Focalin XR 5 mg capsules. The contract, valued at $1,777.68, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,096.88 firm fixed-price delivery order is for 4,562,655,153 units of the prescription drug Focalin XR 10 mg capsules. The contract has an ultimate completion date of October 31, 2023 and was awarded on October 30, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FASA9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for 4,564,220,371 units of Focalin XR 10 mg capsules, with a ceiling value of $3,184.60 and an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/9/24 |